SCHEMBL8486331

SCHEMBL8486331

Cc1nc(NCC(C)(C)N)nc2c(Nc3ccc(F)c(Cl)c3)ncnc12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.47
ERBB2 P04626 5/20 0.47
MAPK1 P28482 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
CD38 P28907 1/20 0.44
AURKA O14965 2/20 0.43
RPS6KB1 P23443 1/20 0.43
STK17A Q9UEE5 1/20 0.43
FBP1 P09467 2/20 0.42
KDR P35968 3/20 0.42
GRM1 Q13255 1/20 0.42
INSR P06213 1/20 0.41
PDGFRB P09619 1/20 0.41
FLT4 P35916 1/20 0.41
CLK1 P49759 1/20 0.41
EPHB4 P54760 1/20 0.41
TEK Q02763 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993332 0.84 EGFR (0.59) EGFRERBB2MAPK1HPGDHTT
SCHEMBL8488129 0.80 EGFR (0.56) EGFRERBB2MAPK1CD38AURKA
SCHEMBL8487455 0.75 EGFR (0.57) EGFRERBB2HPGDHTTCD38
SCHEMBL8487459 0.75 EGFR (0.57) EGFRERBB2HPGDHTTCD38
SCHEMBL8486781 0.75 EGFR (0.57) EGFRERBB2HPGDHTTKDR
SCHEMBL8488224 0.74 EGFR (0.74) EGFRERBB2HPGDHTTKDR
SCHEMBL8566823 0.73 GRM1 (0.64) EGFRERBB2CD38AURKAFBP1
SCHEMBL8569905 0.73 GRM1 (0.55) EGFRERBB2CD38AURKAFBP1
SCHEMBL8488253 0.71 EGFR (0.56) EGFRERBB2MAPK1HPGDHTT
SCHEMBL30683235 0.71 EGFR (0.59) EGFRERBB2MAPK1AURKARPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977102-A INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; DR. KARL THOMAE GMBH (DE) 1999-11-02 US disclosed
EP-0885227-A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1998-12-23 EP disclosed
WO-1997032882-A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed